Drug Profile


Alternative Names: 2-Carboxyethylgermanium sesquioxide; GE 132; Rexagermanium

Latest Information Update: 22 Feb 1999

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Asai Germanium
  • Class Heavy metals
  • Mechanism of Action Glycosylation inhibitors; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cancer; Cataracts; Postmenopausal osteoporosis

Most Recent Events

  • 22 Feb 1999 GE 132 is now called repagermanium
  • 27 Jan 1999 Discontinued-Preclinical for Cataracts in USA (Unknown route)
  • 27 Jan 1999 Discontinued-Preclinical for Postmenopausal osteoporosis in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top